HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Treatment of non accomodated concomitant strabismus].

Abstract
The aim of the study was comparative evaluation of surgical treatment and complex pre and postoperative pleoptic, orthoptic, diploptic treatment of non accommodated concomitant strabismus and identification of the optimum age for surgical treatment of strabismus. The 75 patients (from 2 to 10 years old) with manifested concomitant convergent strabismus were divided into two groups: patients operated at the age from 2 to 4 years old; patients operated at the age of 4-10 years). The 75 of patients operated at the age from 2 to 4 years old, which underwent orthoptic-diploptic treatment pre- and postoperatively got binocular vision showed the full recovery in only 40% of cases of the same age-group undergone the surgical treatment in combination with the direct occlusion. Binocular vision was achieved in 68% of patients operated at the age of 4-10 years with complex treatment, and in 25% in patients of the same age group with surgical treatment plus occlusion. The findings showed the efficacy of complex treatment as well as pre and postoperative pleoptic-orthoptic-diploptic treatment of strabismus and direct occlusion. Thus, the results of this study suggest that the delay of surgical treatment limits the ability to obtain optimal results.
AuthorsM Sh Kikolashvili, D G Shengeliia, L V Tsomaia
JournalGeorgian medical news (Georgian Med News) Issue 191 Pg. 22-6 (Feb 2011) ISSN: 1512-0112 [Print] Georgia (Republic)
PMID21436474 (Publication Type: English Abstract, Journal Article)
Topics
  • Age Factors
  • Child
  • Child, Preschool
  • Cohort Studies
  • Esotropia (surgery, therapy)
  • Humans
  • Orthoptics (methods)
  • Strabismus (physiopathology, surgery, therapy)
  • Vision, Binocular (physiology)
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: